Multidisciplinary quality assurance and control in oncological trials: Perspectives from European Organisation for Research and Treatment of Cancer (EORTC)-Reference-Cited by-同舟云学术

Multidisciplinary quality assurance and control in oncological trials: Perspectives from European Organisation for Research and Treatment of Cancer (EORTC)

Published:2017-11 Issue: Volume:86 Page:91-100
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

de Balincourt Christine^ORCID,Lacombe Denis,Coens Corneel,den Dulk Marcel,Machiels Jean-Pascal,Weber Damien,Spahn Martin,Salgado Roberto,Kasper Bernd,Hau Peter,Licitra Lisa,Betsou Fay,Kataoka Kozo,Caballero Carmela,Liu Yan,Hurkmans Coen,Evrard Serge

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. Quality assurance in clinical trials;Ottevanger;Crit Rev Oncol Hematol,2003

2. EORTC joint ventures in quality control: treatment-related variables and data acquisition in chemotherapy trials;Vantongelen;Eur J Cancer Clin Oncol,1991

3. The value of source data verification in a cancer clinical trial;Tudur Smith;PLoS One,2012

4. Quality control in multicentric clinical trials. An experience of the EORTC Gynecological Cancer Cooperative Group;Favalli;Eur J Cancer,2000

5. A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B;Weiss;JAMA,1993

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EORTC 1409 GITCG/ESSO 01 - A prospective colorectal liver metastasis database for borderline or initially unresectable diseases (CLIMB): Lessons learnt from real life. From paradigm to unmet need;European Journal of Surgical Oncology;2023-11

2. Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases;British Journal of Surgery;2023-05-17

3. The radiotherapy quality assurance gap among phase III cancer clinical trials;Radiotherapy and Oncology;2022-01

4. Challenges needed to be overcome in multi-institutional surgical trials: accumulated experience in the JCOG Colorectal Cancer Study Group (CCSG);Japanese Journal of Clinical Oncology;2021-12-02

5. How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review;Translational Lung Cancer Research;2021-07